Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-24 Sale |
2025-06-24 4:08 pm |
ARVINAS INC. | ARVN | Saik Andrew Chief Financial Officer |
5,700 | $7.61 | $43,377 | 164,401 (Direct) |
View |
| 2023-11-08 Sale |
2023-11-13 2:40 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
45,244 | $19 | $859,636 | 0 (Direct) |
View |
| 2020-09-08 Purchase |
2020-09-08 8:01 pm |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
40,000 | $1.462 | $58,480 | 340,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-10 Option Award |
2025-06-12 4:19 pm |
N/A 2035-06-10 |
Milestone Pharmaceuticals Inc. | MIST | Saik Andrew Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2025-05-09 Option Award |
2025-05-13 5:17 pm |
N/A 2035-05-08 |
ARVINAS INC. | ARVN | Saik Andrew Chief Financial Officer |
150,600 | $0 | 261,101 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 7:59 pm |
N/A 2035-02-12 |
ARVINAS INC. | ARVN | Saik Andrew Chief Financial Officer |
124,052 | $0 | 185,461 (Direct) |
View |
| 2024-08-28 Option Award |
2024-08-29 4:15 pm |
N/A 2034-08-28 |
Milestone Pharmaceuticals Inc. | MIST | Saik Andrew Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-17 4:17 pm |
N/A 2034-07-15 |
Milestone Pharmaceuticals Inc. | MIST | Saik Andrew Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:20 pm |
N/A 2034-06-23 |
ARVINAS INC. | ARVN | Saik Andrew Chief Financial Officer |
155,827 | $0 | 155,827 (Direct) |
View |
| 2023-11-08 Equity Swap |
2023-11-13 2:40 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
23,021 | $19 | 0 (Direct) |
View |
| 2023-09-21 Tax Withholding |
2023-09-25 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
908 | $10.8 | 68,265 (Direct) |
View |
| 2023-06-21 Tax Withholding |
2023-06-23 4:04 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
908 | $11.74 | 69,173 (Direct) |
View |
| 2023-03-21 Tax Withholding |
2023-03-23 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
909 | $14.19 | 70,081 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 4:05 pm |
N/A 2033-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
38,700 | $0 | 94,990 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 4:04 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
718 | $12.37 | 56,290 (Direct) |
View |
| 2022-12-21 Tax Withholding |
2022-12-23 4:03 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
908 | $13.43 | 57,008 (Direct) |
View |
| 2022-09-21 Tax Withholding |
2022-09-23 4:02 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
908 | $14.85 | 57,916 (Direct) |
View |
| 2022-06-21 Tax Withholding |
2022-06-23 4:01 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
3,632 | $12.48 | 58,824 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 4:16 pm |
N/A 2032-01-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
27,900 | $0 | 80,056 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 7:01 pm |
N/A 2031-06-21 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer |
124,696 | $0 | 124,696 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
3,017 | $3.3575 | 116,468 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:14 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
762 | $6.84 | 113,451 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:39 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
97,375 | $0 | 182,375 (Direct) |
View |